The National Institute for Pharmaceutical Research and Development (NIPRD) has promised to support the African Pharmaceutical Technology Foundation recently approved by the African Development Bank’s (AFDB) Board of Directors.
Dr Obi Adigwe, NIPRD’s Director-General, revealed this in a statement issued on Wednesday in Lagos.
According to him, the aim of the Foundation is to enhance Africa’s access to technologies that underpin the manufacture of medicines, vaccines, and other pharmaceutical products.
“After the COVID-19 outbreak, NIPRD emerged as a huge contributor to the national and global response.
“NIPRD provided the internationally-acclaimed analysis that underpinned many African governments’ categorical position on the Madagascan COVID-19 organics preparation.
“This analysis went viral internationally with scientists and policymakers around the world referencing NIPRD’s seminal work on the product with their work; a multitude of lives on the continent were saved.
“Africa conserved millions of dollars that would otherwise have been expended on an unverified product, and research and development resources were prioritised for more effective solutions," he stated.
GlaxoSmithKline Consumer Nigeria Plc was incorporated in Nigeria on 23rd June 19...LEARN MORE
Ekocorp PLC began operations in 1977 as Mercy Specialist Clinic. Within a few ye...LEARN MORE
Neimeth International Pharmaceutical Plc was founded in 1957. The company is th...LEARN MORE